CXCL14 as a potential marker for immunotherapy response prediction in renal cell carcinoma.

Qiwen PanRuiqi LiuXinyue ZhangLingling CaiYilin LiPei DongJianming GaoYang LiuLiru He

Published in: Therapeutic advances in medical oncology (2023)

CXCL14 expression is associated with immunotherapy response in RCC. It is a promising biomarker for immunotherapy response prediction and may be an effective epigenetic modulator in combination with immunotherapy approaches.

Keyphrases

renal cell carcinoma
gene expression
dna methylation
climate change